UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 626

Sortiert nach

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

The Journal of pediatrics, 2017-02, Vol.181, p.S4-S15.e1

2017

Volltextzugriff (PDF)

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis

Chest, 2016-02, Vol.149 (2), p.390-400

2016

Volltextzugriff (PDF)

Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2008-08, Vol.178 (4), p.363-371

2008

Volltextzugriff (PDF)

Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis

The Journal of pediatrics, 2009-12, Vol.155 (6), p.S73-S93

2009

Volltextzugriff (PDF)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience

Pulmonary therapy, 2020-06, Vol.6 (1), p.141-149

2020

Volltextzugriff (PDF)

Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond

The Journal of pediatrics, 2009-12, Vol.155 (6), p.S106-S116

2009

Volltextzugriff (PDF)

Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative

Orphanet journal of rare diseases, 2018-02, Vol.13 (Suppl 1), p.13-13, Article 13

2018

Volltextzugriff (PDF)

Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United States

JNCI : Journal of the National Cancer Institute, 2013-01, Vol.105 (2), p.122-129

2013

Volltextzugriff (PDF)

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry

Annals of the American Thoracic Society, 2016-07, Vol.13 (7), p.1173-1179

2016

Volltextzugriff (PDF)

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry

Annals of internal medicine, 2014-08, Vol.161 (4), p.233

2014

Volltextzugriff (PDF)

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Journal of cystic fibrosis, 2020-01, Vol.19 (1), p.68-79

2020

Volltextzugriff (PDF)

Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis

American journal of respiratory and critical care medicine, 2000-12, Vol.162 (6), p.2302-2307

2000

Volltextzugriff (PDF)

Incidence and Risk Factors for Multiple Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis

Chest, 2007-08, Vol.132 (2), p.562-568

2007

Volltextzugriff (PDF)

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study

Annals of internal medicine, 2017-04, Vol.166 (8), p.537

2017

Volltextzugriff (PDF)

Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic

American journal of respiratory and critical care medicine, 2020-06, Vol.201 (11), p.1434-1435

2020

Volltextzugriff (PDF)

Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

Diabetes care, 2010-12, Vol.33 (12), p.2697-2708

2010

Volltextzugriff (PDF)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients

Respiratory medicine, 2022-03, Vol.193, p.106727-106727, Article 106727

2022

Volltextzugriff (PDF)

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Infection control and hospital epidemiology, 2014-08, Vol.35 (S1), p.S1-S67

2014

Volltextzugriff (PDF)

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-05, Vol.303 (17), p.1707

2010

Volltextzugriff (PDF)

Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative

BMJ quality & safety, 2014-04, Vol.23 (Suppl 1), p.i95-i103

2014

Volltextzugriff (PDF)

Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations

American journal of respiratory and critical care medicine, 2009-11, Vol.180 (9), p.802-808

2009

Volltextzugriff (PDF)

Improving the Care of Infants Identified through Cystic Fibrosis Newborn Screening

The Journal of pediatrics, 2009-12, Vol.155 (6), p.S71-S72

2009

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care

Journal of cystic fibrosis, 2021-12, Vol.20, p.1-2

2021

Volltextzugriff (PDF)

1 – 25 von 626

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(573)
Mit Volltextzugriff
(556)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis

Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis

Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience

Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond

Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative

Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United States

The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry

Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis

Incidence and Risk Factors for Multiple Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic

Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative

Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations

Improving the Care of Infants Identified through Cystic Fibrosis Newborn Screening

Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care

Suchergebnisse filtern